Treatment of tic douloureux with a new anticonvulsant (clonazepam).
AUTOR(ES)
Court, J E
RESUMO
Twenty-five patients affected by 30 episodes of tic douloureux were treated with a new anticonvulsant, clonazepam. In 40% there was complete control of the neuralgia and an additional 23.3% were significantly helped by the drug. Sixteen patients had previously been resistant to carbamazepine, and eight of them were completely and one partially relieved by clonazepam. The side-effects, somnolence and unsteadiness of gait, were present to some extent in 80 and 88% of the cases respectively, being severe in about half of them. It is concluded that clonazepam can be considered as a second choice for the treatment of this condition, after proven failure with carbamazepine. Possible mechanisms of action are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492269Documentos Relacionados
- SYMPATHECTOMY FOR TIC DOULOUREUX
- Precise alcoholic Gasserian injection for tic douloureux1
- Treatment of epilepsy with clonazepam and its effect on other anticonvulsants.
- The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin.
- NewIn-situ synthesis method of magnesium matrix composites reinforced with TiC particulates